Concepedia

Chiara Monfrini

CM

4

Publications

121

Citations

4

H-Index

2021

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Milan

Humanitas University

IRCCS Humanitas Research Hospital

Chiara Monfrini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, immunology, and tumor biology.

ORCID

Top concepts

Publications per year

2021–2022

4

Publications

4

Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects <i>In Vivo</i> Expansion and Disease Response in Patients with Large B-cell Lymphoma

Chiara Monfrini, Federico Stella, Vanessa Aragona et al. · Clinical Cancer Research · 2022 · 54 citations · Full text

Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome

Anna Dodero, Anna Guidetti, Fabrizio Marino et al. · Haematologica · 2021 · 33 citations · Full text

, , +18

Chemotherapy after <scp>PD</scp>‐1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics

Eleonora Calabretta, Anna Guidetti, Francesca Ricci et al. · British Journal of Haematology · 2022 · 20 citations · Full text

Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti‐CD19 chimeric antigen receptor T‐cell efficacy

Anna Guidetti, Anna Dodero, Alice Lorenzoni et al. · Cancer · 2022 · 14 citations · Full text

Rows per page

1–4 of 4